Table 1 Patient characteristics of all patients enrolled in this study

Mean ± SD*

45.82 ± 14.67

49.19 ± 15.26

0.152^c

Median (25th-75th)^¶

48.00(35.50-57.00)

52.50(44.50-59.00)

0.095^a

Sex ^§

Male count (%)

21(37.5%)

22(37.3%)

0.862^b

Female count (%)

35(62.5%)

37(62.7%)

Weight ( kg) ^*

74.54 ± 28.01

76.04 ± 18.81

0.609^c

Bil (mg/dL)^*

10.54 ± 4.89

12.09 ±6.83

0.42^c

ALT (IU/L)^*

76.59 ±57.5

82.2 ± 76.2

0.424^c

AST (IU/L)^*

59.27 ± 43.37

53.63 ± 55.81

0.14^c

ALP (IU/L)^*

98.4 ± 67.8

116.13 ± 60.98

0.538^c

AFP (ng/mL)^*

8.22 ±17.12

7.76 ± 18.18.47

0.904^c

HCV load log10^¶

5.74(5.21-6.40)

5.88(5.15-6.48)

0.837^a

Median (25th-75th)^¶

Stage ^§

≤2 count (%)

24(77.4%)

21(63.6%)

0.227^b

≥3 count (%)

7(22.6%)

12(36.4%)

Grade ^§

≥1 count (%)

8(25%)

8(22.2%)

0.788^b

3 count (%)

24(75%)

28(77.8%)

Genotypes ^§

4a (%)

39(58%)

28(42%)

0.02^b

4d (%)

17(35%)

31(65%)